We understand the challenges involved in the development of bioanalytical assays to measure levels of large molecule drugs or anti-drug antibodies. You need to design a selective and sensitive assay that works every time, generate translatable and defensible data, and meet your deadlines.
We know you need trustworthy critical antibody reagents to do this. Without high quality antibodies you can get stuck developing the method, have to continually requalify new lots, end up feeling insecure about the results, and frustrated about not making progress.
We offer over a hundred antibodies against marketed biologic drugs suitable for pharmacokinetic (PK) and anti-drug-antibody (ADA) assays, to support bioanalytical assays for preclinical research and clinical trials, and therapeutic drug monitoring, for innovator and biosimilar products.
Our team of antibody experts has been making recombinant monoclonal antibodies targeting large molecule biologics for over 10 years, with 100% success for inhibitory anti-idiotypic antibodies.
Imagine how good it would feel to save time and increase your success rates
You have well characterized antibodies, highly specific to the drug
You can design and optimize a selective and sensitive assay
Your results are translatable and reproducible
Trust our recombinant anti-idiotypic antibodies to help you master the assay, deliver results, increase productivity and achieve success!